Weight loss surgery more ‘cost saving’ over long term vs. semaglutide for class II obesity
Endoscopic sleeve gastroplasty was more cost-effective and sustained greater weight loss over 5 years compared with semaglutide for patients with class II obesity, according to data published in JAMA Network Open. “Endoscopic sleeve gastroplasty (ESG) is the most effective endoscopic bariatric and metabolic therapy that is attracting attention worldwide,” Muhammad Haseeb, MD,